Skip to main content

Biocept Inc

BIOCDelisted Nov 20, 2023
Industry
Services-Medical Laboratories
SEC CIK
0001044378

Biocept Inc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Nov 18, 2022; 26 institutions reported holding it in 13F filings for Q1 2023, worth $304.2K in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding Biocept Inc changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of BIOC: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders2926−3
Shares1.71M1.53M−183.0K (−10.7%)
Value$1.57M$807.7K−$764.3K (−48.6%)

New holders (4)

Institutions that held Biocept Inc at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to BIOC in Q4 2022
InstitutionSharesValue% of portfolio
Connective Capital Management, LLC108,280$57.4K0.02%
Virtu Financial LLC23,001$12.0K0.00%
Citadel Advisors LLC10,396$5.51K0.00%
Bank of America Corp540$2870.00%

Sold out (7)

Institutions that held Biocept Inc at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of BIOC in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Globeflex Capital L P233,578$215.0K
Millennium Management LLC37,018$34.0K
Two Sigma Advisers, LP14,000$13.0K
Dimensional Fund Advisors LP12,848$12.0K
Castle Wealth Management LLC1,350$1.00K
FMR LLC1$0
Morgan Stanley6$0